Helping Ovarian Cancer Patients Cope With Their Illness (HOPE)

Not Applicable
Not yet recruiting
Conditions
Registration Number
NCT06666218
Lead Sponsor
Fred Hutchinson Cancer Center
Brief Summary

This clinical trial compares the effect of the Helping Ovarian Cancer Patients Cope with Their Disease (HOPE) intervention to usual care for the reduction of hopelessness and helplessness in patients with ovarian cancer that has come back after a period of improvement (recurrent). Patients with recurrent ovarian cancer are at high risk for increased death an...

Detailed Description

OUTLINE:

AIM 1: Patients complete the HOPE intervention workshop virtually or in-person. The workshop consists of 3 sessions, each held once per week and lasting 60 to 90 minutes as well as complete a survey and an interview for HOPE intervention refinement during follow up.

AIM 2: Patients are randomized to 1 of 2 groups.
...

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Age 18 years of age or older
  • English speaking
  • Able to provide informed consent
  • Current diagnosis of recurrent epithelial ovarian cancer (regardless of the amount of time since the diagnosis, given the poor prognosis of this illness with a median survival time of less than 2 years)
Read More
Exclusion Criteria
  • Patients with non-invasive gynecologic disease (i.e., dysplasia)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Accrual rates (Aim 1)At the time of enrollment

Feasibility will be assessed by accrual rates. Feasibility cutoffs will include \>= 50% of eligible patients will enroll in the study.

Fidelity rates (Aim 1)Up to 28 days

Feasibility will be assessed by fidelity rates. Feasibility cutoffs will include \>= 75% of HOPE workshop sessions delivered with fidelity.

Rates of intervention completion (Aim 1)Up to 28 days

Feasibility will be assessed by rates of intervention completion (all three sessions of Helping Ovarian Cancer Patients Cope with Their Disease \[HOPE\]). Feasibility cutoffs will include 70% of enrolled patients will complete all workshop sessions.

Acceptability of the HOPE intervention (Aim 1)Up to 28 days

Acceptability will be assessed by the Theoretical Framework of Acceptability (TFA) questionnaire, which is an 8-item questionnaire assessing acceptability of healthcare interventions across seven constructions: affective attitude, burden, ethicality, intervention coherence, opportunity costs, perceived effectiveness and self-efficacy. The eighth item is a ge...

Overall satisfaction (Aim 1)Up to 28 days

Satisfaction will be assessed by using three items assessing overall satisfaction (How satisfied are you? How likely are you to recommend to someone? How likely would you participate in this workshop knowing what it is like now?). A cutoff score of \>= 7 (out of 10) will be used as a cutoff for each satisfaction item.

Hopelessness/helplessness (Aim 2)Baseline to 12 weeks post-randomization

Hopelessness/helplessness will be measured by the helplessness/hopelessness subscale of the Mental Adjustment to Cancer (MAC) scale. The MAC scale is a widely used, 40-item scale that assesses patients' psychological responses to cancer. Items are given as statements (e.g., "I feel that life is hopeless") and patients report their agreement using a 4-point L...

Secondary Outcome Measures
NameTimeMethod
Documentation of advance care planning (ACP) conversations (Aim 2)Baseline to 5 weeks post-randomization

Engagement in ACP will be measured by documentation of ACP conversations using an 8-item measure of discussing end-of-life care, living will, health care proxy (HCP), and do-not-resuscitate (DNR) orders with family and doctor

Accrual rates (Aim 2)At the time of enrollment

Feasibility will be assessed by accrual rates. Feasibility will be examined by conducting frequency and descriptive statistics for enrollment rates. The benchmark for feasibility is \>= 50% of screened eligible patients enroll in the study. Feasibility process outcomes will be analyzed to determine whether the intervention is feasible for future disseminatio...

Rates of intervention completion (Aim 2)Up to 35 days

Feasibility will be assessed by rates of intervention completion (all three sessions of HOPE). Feasibility will be examined by conducting frequency and descriptive statistics for intervention workshop completion. The benchmark for feasibility is \>= 70% of enrolled patients will complete the intervention (e.g., complete all workshop sessions). Feasibility pr...

Acceptability of the HOPE intervention (Aim 2)5-weeks post-randomization

Acceptability will be assessed by the TFA questionnaire, which is an 8-item questionnaire assessing acceptability of healthcare interventions across seven constructions: affective attitude, burden, ethicality, intervention coherence, opportunity costs, perceived effectiveness and self-efficacy. The eighth item is a general acceptability item. Items are rated...

Distress (Aim 2)Baseline to 5 weeks post-randomization

Distress will be assessed using two measures. (1) The Patient Health Questionnaire which is an 8-item questionnaire assessing depression on a 4-point Likert scale (0 = not at all, 3 = nearly every day). (2) The Generalized Anxiety Disorder, which is a 7-item self-report anxiety measure asking about how commonly feelings of anxiety are experienced (0 = not at...

Quality of life (QOL) (Aim 2)Baseline to 5 weeks post-randomization

QOL will be assessed using the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) scale. The FACT-O is a 39-item, validated scale that assesses the five domains of QOL among ovarian cancer patients: physical, functional, social/family, emotional, and additional concerns related to ovarian cancer. All items are rated on a 5-point Likert scale (0 to 4), ...

Self-efficacy for treatment decision-making (Aim 2)Baseline to 5 weeks post-randomization

Self-efficacy for treatment decision-making will be measured by Decision-Making Participation Self-Efficacy (DEPS) scale. The DEPS scale is a 5-item validated measure that assesses cancer patients' confidence in engaging in difference activities related to decision-making. Patients are asked to indicate how confident they are that they would be able to engag...

Readiness for advance care planning (ACP) (Aim 2)Baseline to 5 weeks post-randomization

Engagement in ACP will be measured by readiness for ACP using the reliable and valid Advance Care Planning Readiness Scale to assess readiness for end-of-life care conversations.

Level of Engagement in advance care planning (ACP) (Aim 2)Baseline to 5 weeks post-randomization

Engagement in ACP will be measured by level of engagement in ACP using the reliable and valid Advance Care Planning Engagement Survey: Action Measures

Completion of advance care directives (Aim 2)Baseline to 5 weeks post-randomization

Engagement in ACP will be measured by completion of advance directives by asking patients whether they have completed a DNR order, living will, or identified a HCP. All advance directives data will be verified through the patient's electronic health record. Will use mixed effects models (linear and logistic). The mixed models will have a patient-level random...

Trial Locations

Locations (1)

Fred Hutch/University of Washington Cancer Consortium

🇺🇸

Seattle, Washington, United States

© Copyright 2024. All Rights Reserved by MedPath